Dr. Robert M. Davidson, M.D
Cardiology (Cardiovascular Disease Physician)
8635 W 3rd St, Ste# 1050 W
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (1966)
- Years since graduation
- 60
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 282
Licensed in California since 1972, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1966Medical school: New York University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
CA license G22792 (first issued 1972; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 282
- Services billed
- 2,801
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 471 | 230 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 338 | 35 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 301 | 40 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 288 | 208 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 288 | 37 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 238 | 44 |
| Established patient office or other outpatient visit, 20-29 minutes | 130 | 78 |
| Established patient office or other outpatient visit, 40-54 minutes | 73 | 64 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 47 | 38 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 40 | 14 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 66 payments worth $2,067 in total to this clinician.
| E.r. Squibb & Sons, L.l.c. | $342 |
|---|---|
| Novartis Pharmaceuticals Corporation | $312 |
| Novo Nordisk Inc | $262 |
| Heartflow, Inc. | $224 |
| Regeneron Healthcare Solutions, Inc. | $118 |
| Amgen Inc. | $109 |
| Edwards Lifesciences Corporation | $106 |
| Bridgebio Pharma, Inc. | $83.80 |
| Food and Beverage | $1,996 |
|---|---|
| Education | $71.33 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Idorsia Pharmaceuticals US Inc Aug 7, 2025 | Education Tryvio · Hypertension · in-kind | $52.48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Jun 3, 2025 | Education JARDIANCE · DIABETES · in-kind | $18.85 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.